A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Clinical Trial ID NCT00395070

PubWeight™ 6.72‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00395070

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol 2013 2.64
2 Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use. P T 2012 1.19
3 Developments in Intralesional Therapy for Metastatic Melanoma. Cancer Control 2016 0.77
4 New clinical advances in immunotherapy for the treatment of solid tumours. Immunology 2015 0.76
5 Nanocarrier-based immunotherapy in cancer management and research. Immunotargets Ther 2014 0.76
6 Immunotherapy in the management of melanoma: current status. Immunotargets Ther 2013 0.75
Next 100